Biopharma giants Eli Lilly and Regeneron and rapidly growing contract manufacturers Fujifilm and Cellares are among the seven ...
Mandatory reviews by top health officials and checks for 235 disfavoured terms have left hundreds of vetted grant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results